Lundbeck Inc. (formerly Ovation Pharmaceuticals) CFO: Elan Pharmaceuticals Not an Acquisition Option Now

Published: May 13, 2009

Bookmark and Share

COPENHAGEN, May 13 (Reuters) - Danish pharmaceutical group Lundbeck (LUN.CO) would not be able to buy Irish biotech company Elan (ELN.I) in current market conditions, Lundbeck's Chief Financial Officer Anders Gotzsche said on Wednesday.

Back to news